| Next 10 |
CMAX News and Press CareMax Inc.
-
2023-03-20 13:07:07 ET Gainers: Loyalty Ventures ( LYLT ) +97% . Ambipar Emergency ( AMBI ) +73% . Lifecore Biomedical ( LFCR ) +60% . InMed Pharmaceuticals ( INM ) +43% . New York Community Bancorp ( NYCB ) +32% . Harbor Cus...
-
2023-03-20 10:29:09 ET Gainers: Lifecore Biomedical ( LFCR ) +41% . Connect Biopharma ( CNTB ) +27% . InMed Pharmaceuticals ( INM ) +21% . ReShape Lifesciences ( RSLS ) +21% . Bellerophon Therapeutics ( BLPH ) +15% . Losers...
-
2023-03-17 10:02:41 ET Gainers: Enzo Biochem ( ENZ ) +77% . PaxMedica ( PXMD ) +22% . Nuwellis (NUWE ) +18% . Lucy Scientific Discovery ( LSDI ) +12% . Assure Holdings ( IONM ) +8% . Losers: Lifecore Biomedical (...
-
2023-03-10 11:41:50 ET Gainers: Euda Health ( EUDA ) +53% . Unicycive ( UNCY ) +27% . Tenon Medical ( TNON ) +12% . Rain ( RAIN ) +11% . Altamira ( CYTO ) +11% . Losers: Meihua International ( MHUA ) -34% . Fr...
-
2023-03-09 11:38:01 ET CareMax, Inc. (CMAX) Q4 2022 Results Conference Call March 09, 2023 08:30 AM ET Company Participants Samantha Swerdlin - VP, IR Carlos de Solo - CEO Kevin Wirges - CFO Conference Call Participants Joshua Raskin - Nephron Researc...
-
2023-03-09 06:59:57 ET CareMax press release ( NASDAQ: CMAX ): Q4 GAAP EPS of $0.10 beats by $0.15 . Revenue of $164.26M (+38.9% Y/Y) beats by $13.65M . Adjusted EBITDA (including the impact of de novo pre-opening costs and post-opening losses) was $5.1 million...
-
Exceeded 2022 Guidance for Membership and Revenue and Met 2022 Guidance for Adjusted EBITDA (Inclusive of De Novo Pre-Opening Costs and Post-Opening Losses) Year-end 2022 Medicare Advantage Membership of 93,500, up 179% year-over-year Full Year 2022 Total Revenue of $631 million, ...
-
The Company will also report fourth quarter and full year 2022 results on March 9 CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that it will host an Investor Day for analysts and...
-
Summary P3 Health Partners’ guidance breaks the billion-dollar mark in 2022 revenues. P3 Health Partners anticipates that its Adjusted EBITDA will be positive in 2024. P3 Telehealth and more advanced Digital Health and Telehealth support platforms coming to market can substan...
-
Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Investors are eager to herald a return to low inter...
Stock Information
CareMax Inc. Company Name:
CMAX Stock Symbol:
NASDAQ Market:
Get CMAX Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
